|
業務類別
|
-- |
|
業務概覽
|
Japan Tobacco primarily sells cigarettes and reduced-risk products, organized in three clusters consisting of Asia (which includes its home market and countries in Asia Pacific), Western Europe, and EMA (which includes Eastern Europe, the Middle East North Africa, Turkey, Americas, and duty-free). Its leading cigarette brands include Winston (non-US), Camel (non-US), Mevius, and LD. Its reduced-risk brands include Logic in vaping, Ploom in heated tobacco, and Nordic Spirit in nicotine pouches, though these generates less than 5% of tobacco sales. |
| 公司地址
| 4-1-1 Toranomon, Minato-ku, Tokyo, JPN, 105-6927 |
| 電話號碼
| +81 366362914 |
| 傳真號碼
| +81 355721441 |
| 公司網頁
| https://www.jti.co.jp |
| 員工數量
| 59297 |
| Mr. Kei Nakano |
Director and Executive Vice President, Finance, Corporate Communications, Business Development and D-LAB |
-- |
26/03/2025 |
| Mr. Masamichi Terabatake |
Chief Executive Officer, Director and President |
-- |
26/03/2025 |
| Mr. Koji Shimayoshi |
Director and Executive Vice President, Corporate Governance, Compliance, Corporate Strategy, Sustainability, People & Culture, Information Technology, Legal, Operation Review & Business Assurance, Pharmaceutical Business and Food Business |
-- |
26/03/2025 |
|
|
| Mr. Kei Nakano |
Director and Executive Vice President, Finance, Corporate Communications, Business Development and D-LAB |
26/03/2025 |
| Mr. Tetsuya Shoji |
Independent Director |
26/03/2025 |
| Ms. Hiroko Yamashina |
Independent Director |
26/03/2025 |
| Mr. Mutsuo Iwai |
Chairman of the Board |
26/03/2025 |
| Mr. Masamichi Terabatake |
Chief Executive Officer, Director and President |
26/03/2025 |
| Ms. Yukiko Nagashima |
Independent Director |
26/03/2025 |
| Mr. Shigeaki Okamoto |
Deputy Chairman of the Board |
26/03/2025 |
| Mr. Masato Kitera |
Independent Director |
26/03/2025 |
| Mr. Koji Shimayoshi |
Director and Executive Vice President, Corporate Governance, Compliance, Corporate Strategy, Sustainability, People & Culture, Information Technology, Legal, Operation Review & Business Assurance, Pharmaceutical Business and Food Business |
26/03/2025 |
| Mr. Kenji Asakura |
Independent Director |
26/03/2025 |
|
|
|
|
